Cargando…
Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816059/ https://www.ncbi.nlm.nih.gov/pubmed/33471294 http://dx.doi.org/10.1007/s12185-021-03078-x |
_version_ | 1783638365011181568 |
---|---|
author | Iba, Toshiaki Connors, Jean Marie Spyropoulos, Alex C. Wada, Hideo Levy, Jerrold H. |
author_facet | Iba, Toshiaki Connors, Jean Marie Spyropoulos, Alex C. Wada, Hideo Levy, Jerrold H. |
author_sort | Iba, Toshiaki |
collection | PubMed |
description | Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to thrombogenicity have been reported and the incidence of thromboembolic events is considered to be lower in the Asian population. Despite the importance of thromboprophylaxis, bleeding is also a side effect that should be considered. We examine the data relating to potential ethnic differences in thrombosis and bleeding in COVID-19. Although sufficient data is not yet available, current evidence does not oppose routine anticoagulant use and thromboprophylaxis using a standard dose of LMWH for admitted patients regardless of ethnicity based on our review. |
format | Online Article Text |
id | pubmed-7816059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-78160592021-01-21 Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? Iba, Toshiaki Connors, Jean Marie Spyropoulos, Alex C. Wada, Hideo Levy, Jerrold H. Int J Hematol Review Article Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to thrombogenicity have been reported and the incidence of thromboembolic events is considered to be lower in the Asian population. Despite the importance of thromboprophylaxis, bleeding is also a side effect that should be considered. We examine the data relating to potential ethnic differences in thrombosis and bleeding in COVID-19. Although sufficient data is not yet available, current evidence does not oppose routine anticoagulant use and thromboprophylaxis using a standard dose of LMWH for admitted patients regardless of ethnicity based on our review. Springer Singapore 2021-01-20 2021 /pmc/articles/PMC7816059/ /pubmed/33471294 http://dx.doi.org/10.1007/s12185-021-03078-x Text en © Japanese Society of Hematology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Iba, Toshiaki Connors, Jean Marie Spyropoulos, Alex C. Wada, Hideo Levy, Jerrold H. Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? |
title | Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? |
title_full | Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? |
title_fullStr | Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? |
title_full_unstemmed | Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? |
title_short | Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? |
title_sort | ethnic differences in thromboprophylaxis for covid-19 patients: should they be considered? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816059/ https://www.ncbi.nlm.nih.gov/pubmed/33471294 http://dx.doi.org/10.1007/s12185-021-03078-x |
work_keys_str_mv | AT ibatoshiaki ethnicdifferencesinthromboprophylaxisforcovid19patientsshouldtheybeconsidered AT connorsjeanmarie ethnicdifferencesinthromboprophylaxisforcovid19patientsshouldtheybeconsidered AT spyropoulosalexc ethnicdifferencesinthromboprophylaxisforcovid19patientsshouldtheybeconsidered AT wadahideo ethnicdifferencesinthromboprophylaxisforcovid19patientsshouldtheybeconsidered AT levyjerroldh ethnicdifferencesinthromboprophylaxisforcovid19patientsshouldtheybeconsidered |